These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20524257)

  • 61. Can innate immune system targets turn up the heat on 'cold' tumours?
    Mullard A
    Nat Rev Drug Discov; 2018 Dec; 17(1):3-5. PubMed ID: 29282375
    [No Abstract]   [Full Text] [Related]  

  • 62. [Development of anti-cancer drug: past and future].
    Mano H
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():11-5. PubMed ID: 25831717
    [No Abstract]   [Full Text] [Related]  

  • 63. [Perspectives of improvement of chemotherapy effectiveness in disseminated solid tumors].
    Sivashinskiĭ MS
    Vopr Onkol; 2004; 50(2):237-42. PubMed ID: 15176230
    [No Abstract]   [Full Text] [Related]  

  • 64. Response and survival in clinical trials.
    Omura GA
    J Clin Oncol; 1986 Jun; 4(6):1013. PubMed ID: 3711954
    [No Abstract]   [Full Text] [Related]  

  • 65. Use of new cancer drugs in India.
    Pal SK
    Lancet Oncol; 2001 Dec; 2(12):716. PubMed ID: 11902509
    [No Abstract]   [Full Text] [Related]  

  • 66. 2017 ASCO Annual Meeting.
    Yaqub F
    Lancet Oncol; 2017 Jul; 18(7):853-854. PubMed ID: 28602776
    [No Abstract]   [Full Text] [Related]  

  • 67. Inclusion of biopsies in clinical trials of oncology drugs.
    Tam AL
    Clin Adv Hematol Oncol; 2020 Mar; 18(3):144-146. PubMed ID: 32609661
    [No Abstract]   [Full Text] [Related]  

  • 68. Clinical trial of anticancer drug in dogs.
    Carvalho S; Stell A; Lara-Garcia A
    Vet Rec; 2013 Jul; 173(1):23-4. PubMed ID: 23832909
    [No Abstract]   [Full Text] [Related]  

  • 69. Some benefit of concurrent chemo-radiotherapy in cancer.
    Hager T
    JAMA; 1983 Jul 22-29; 250(4):457-8. PubMed ID: 6345822
    [No Abstract]   [Full Text] [Related]  

  • 70. Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery.
    Marron TU; Galsky MD; Taouli B; Fiel MI; Ward S; Kim E; Yankelevitz D; Doroshow D; Guttman-Yassky E; Ungar B; Mehandru S; Golas BJ; Labow D; Sfakianos J; Nair SS; Chakravarty D; Buckstein M; Song X; Kenigsberg E; Gnjatic S; Brown BD; Sparano J; Tewari A; Schwartz M; Bhardwaj N; Merad M
    Nat Med; 2022 Apr; 28(4):626-629. PubMed ID: 35347282
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Drug industry's credibility].
    Methi T
    Tidsskr Nor Laegeforen; 2010 Jul; 130(13):1330; author reply 1331. PubMed ID: 20596106
    [No Abstract]   [Full Text] [Related]  

  • 72. [One can rely on drug industry].
    Kjeken M
    Tidsskr Nor Laegeforen; 2010 Jul; 130(13):1330; author reply 1331. PubMed ID: 20596105
    [No Abstract]   [Full Text] [Related]  

  • 73. Reversal of cancer.
    Lancet; 1983 Apr; 1(8328):799-800. PubMed ID: 6132134
    [No Abstract]   [Full Text] [Related]  

  • 74. Randomized vs. historical clinical trials. Are the benefits worth the cost?
    Dupont WD
    Am J Epidemiol; 1985 Dec; 122(6):940-6. PubMed ID: 3904415
    [No Abstract]   [Full Text] [Related]  

  • 75. Chemical Biology as a Driver of Innovation in Cancer Research and Drug Discovery.
    Kostic M; Arkin M
    Cell Chem Biol; 2017 Sep; 24(9):1057. PubMed ID: 28938086
    [No Abstract]   [Full Text] [Related]  

  • 76. Too few medicines for children with cancer.
    Herold R; Saint-Raymond A; Norga K
    JAMA Pediatr; 2014 Jun; 168(6):583. PubMed ID: 24886801
    [No Abstract]   [Full Text] [Related]  

  • 77. Too few medicines for children with cancer--reply.
    Adamson PC
    JAMA Pediatr; 2014 Jun; 168(6):583-4. PubMed ID: 24886802
    [No Abstract]   [Full Text] [Related]  

  • 78. Challenges in drug development for children.
    Adamson PC
    Clin Adv Hematol Oncol; 2017 Jan; 15(1):26-29. PubMed ID: 28212366
    [No Abstract]   [Full Text] [Related]  

  • 79. [The clinical trials of China innovative new anti-cancer drugs].
    Shi YK; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2019 Jan; 41(1):68-72. PubMed ID: 30678420
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Anticancer drug R&D landscape in China.
    Zhao S; Zhao H; Lv C; Gong J; Zhang J; Fang W; Li J; Hu X; Ba Y; Xu B; Zhang Y; Fan Y; Li K; Chen X; Yang Z; Shen L; Zhang L
    J Hematol Oncol; 2020 May; 13(1):51. PubMed ID: 32404176
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.